Butylphthalide has a certain therapeutic effect on the treatment of cerebral infarction, but can not completely cure cerebral infarction, because everyone’s condition and individual differences are different.
Cerebral infarction is cerebral infarction, also known as ischemic stroke, butylphthalein can reduce the content of arachidonic acid, increase the level of cerebral vascular endothelial carbon monoxide and prostacyclin Ⅱ, and inhibit the release of glutamate and reduce the concentration of intracellular calcium and other pathways to play a role in the treatment of mild to moderate acute strokes, so butylphthalein can be used for the treatment of mild to moderate acute strokes.
Butephthalide is currently available in capsule and injection types of drugs, butephthalide adverse reactions are mainly mild transaminase transient elevation, usually after discontinuation of the drug can return to normal, occasionally nausea, abdominal discomfort and psychiatric symptoms and so on. It is forbidden for those who are allergic to the product, those who have serious bleeding tendency, and those who are allergic to celery.
Therefore, butylphthalide used in the treatment of cerebral infarction needs to be under the guidance of a doctor.